top of page
LogoWix.jpg
Search

Regenerative Research Roundup – July 2026

Welcome to the Regenerative Research Roundup, where we look through recently published research and bring you the best of the best in a quick-to-read digest.


This month, we explore:

  • A network meta-analysis of 18 RCTs asking which PRP add-on actually earns its place: HA, stem cells, or ozone

  • A real-world head-to-head where a non-crosslinked, hybrid-MW HA held its own in two injections against three of PRP

  • A meta-analysis of 16 trials confirming that PRP+HA pulls ahead of PRP alone

  • A double-blinded RCT where the pain endpoint was negative, but PRP delivered a significant reduction in bone marrow edema on MRI

  • A case report using 34 injections over 15 months to treat one patient's knees, and what that tells us about dose versus repetition


Let's dive in!


Comparative Efficacy of Platelet-Rich Plasma Monotherapy Versus Combination Therapies for Knee Osteoarthritis: A Systematic Review and Network Meta-analysis


Journal of Orthopaedic Surgery and Research // LOE: I


A cross-network meta-analysis of 18 RCTs (n=1,376) comparing intra-articular PRP alone against PRP combined with hyaluronic acid (HA), mesenchymal stem cells (MSCs), or ozone (O3) for knee OA. Primary outcomes were changes in WOMAC total score and VAS pain, with treatments calculated and ranked by SUCRA.


Key Findings:

  • For WOMAC function, PRP + HA was the only combination to demonstrate a statistically significant improvement over PRP alone - For VAS pain, PRP + HA was the only combination to demonstrate superior pain relief

  • SUCRA values ranked PRP + HA highest for VAS pain and second for WOMAC function


Clinical Perspective:


When you line up the combination strategies head-to-head, HA is the one that earns its place as the gold standard among PRP.  Of the three add-ons tested, only HA produced a statistically significant improvement over PRP alone and it did so on both pain and function.


The mechanism the authors propose is one that keeps surfacing across the literature: the two agents work on complementary timescales.  HA provides immediate mechanical benefit restoring synovial fluid viscosity and elasticity, improving joint lubrication, and attenuating nociceptive input from mechanically stressed tissues.  While PRP's effects are delayed and sustained, mediated by the gradual release of growth factors that suppress inflammatory pathways (inhibiting NF-κB signaling, reducing IL-1β and TNF-α), promote chondrocyte anabolic activity, and potentially enhance matrix synthesis.  Pairing a fast-acting mechanical effect with a slow-acting biological one is what likely explains the durable benefit across both outcome domains.

 

For a sports-MSK practice deciding where to spend an extra injection, the evidence points cleanly at HA rather than at the higher-cost biologic combinations.


________________________________________________________________ 


Comparative Short-Term Clinical Outcomes of Hybrid Hyaluronic Acid and Platelet-Rich Plasma Injections in Knee Degenerative Conditions: An Exploratory Real-World Retrospective Study


Medicina // LOE: III


Retrospective real-world study comparing HA versus PRP in 40 treated knees with symptomatic degenerative knee conditions. The HA group received two injections of a hybrid high-/low-molecular-weight formulation, while the PRP group received three injections. Outcomes were assessed in both pain and function, measured via the NRS and WOMAC scales, from baseline to end-of-cycle follow-up.


Key Findings:

  • Both groups showed substantial pain improvements:  NRS fell from 6.26 to 2.26 (HA) and 6.76 to 2.29 (PRP), with no significant difference between groups

  • Both groups dispayed substantial functional improvements:  WOMAC improved by 25.42 points (HA) vs 20.19 points (PRP) 


Clinical Perspective:


The value of this study lies less in the “no significant difference” and more in the quality of the comparators used. 

 

In favour of the HA, two injections managed to obtain measurable pain and function scores compared to three injections of PRP.  The HA formulation: hybrid low-molecular weight / high-molecular weight, non-crosslinked, non-animal origin managed to hold its own with the Arthrex Angel commercial system – further highlighting that HA performance is a function of formulation. 

 

A notable limitation is that the second and third PRP injections were administered from frozen–thawed aliquots. Because freezing can induce platelet degranulation and modify the biological activity of PRP, these results may not be fully representative of protocols using fresh PRP at each treatment session.

 

Both the PRP and HA groups produced clinically meaningful outcomes in pain and function, with no significant differences observed between groups.  For clinicians, this study reinforces that formulation characteristics of HA, and dosing characteristics of PRP matter much more in the broader comparison of HA and PRP.



The Efficacy and Safety of Intra-Articular Platelet-Rich Plasma Combined with Hyaluronic Acid Versus PRP Alone: A Meta-Analysis

 

PLOS ONE // LOE: I

 

Meta-analysis of 16 studies (1,384 patients) comparing intra-articular PRP+HA with PRP alone for knee OA.  Outcomes were measured across VAS pain, WOMAC total, Lequesne index, and adverse events, at 1, 3, 6 and 12 months post treatment.

 

Key Findings:

  • No significant difference between groups at 3 months, but PRP+HA demonstrated greater improvements in pain and function at 6 and 12 months.

  • WOMAC scores favored PRP+HA at both 6 months and 12 months, with superior long-term pain relief on VAS.

  • The Lequesne index also favored combination therapy, while adverse events were less frequent in the PRP+HA group.

 

Clinical Perspective:

 

To no surprise, combination therapy once again outperformed PRP alone, with the separation emerging at 6-12 months rather than early follow-up.  While PRP and HA preparations are highly variable, the overall clinical narrative remains consistent: PRP+HA provides greater improvements in pain, function, and safety than PRP alone.

 


Clinical Efficacy of Platelet-Rich Plasma and Hyaluronic Acid Versus Hyaluronic Acid for Knee Osteoarthritis with MRI Analysis: A Randomized Controlled Trial

 

Journal of Clinical Medicine // LOE: I

 

Double-blinded RCT of 58 knees (KL grade 2–3) randomized to intra-articular HA+PRP or HA alone, both given as two injections at 2–4 week intervals.  Primary outcome was VAS pain at 12 months, secondary outcomes were WOMAC, EQ-5D-5L quality of life, and structural change on MRI via the Whole-Organ MRI Score (WORMS), at 12 months.  The HA+PRP group used RegenLab Cellular Matrix A-CP HA, the HA alone group used Orthovisc.

 

Key Findings:

  • VAS at 12 months showed no significant difference between groups and the gap did not exceed the MCID

  • The HA group arm showed greater early pain relief, significant at 1 month and 6 months, though neither difference exceeded the MCID

  • At 12 months, HA+PRP produced a significant reduction in bone marrow edema compared to a slight increase in the HA alone

 

Clinical Perspective:

 

At first glance, this appears to be a negative study for combination therapy: HA alone matched or outperformed HA+PRP on pain outcomes, and the primary endpoint was not met.  However, the comparison is more nuanced than it first appears.

 

Both groups received non-crosslinked, biofermented HA products, yet the formulations differed substantially.  The HA+PRP combination group carried a 1550 kDa HA, while the Orthovisc arm spanned 1000–2900 kDa, a broader, higher-topping molecular-weight profile that likely contributed to its stronger early pain response.


Interestingly under MRI, the HA+PRP group demonstrated a significant reduction in bone marrow edema while the HA-alone group did not.  Given how low the platelet concentration reported in the PRP preparation (1.5-1.6× platelet fold), which was further diluted after being mixed with HA, it’s quite surprising that the MRI picked up signal for a reduction in edema and structural improvement.  

 

For clinicians, the takeaway is twofold: HA formulation matters, and conclusions about PRP efficacy should be interpreted cautiously when platelet dose and biologic characterization are limited.

 


Ultrasound-Guided Long-Term Platelet-Rich Plasma Injections for Moderate-to-Severe Knee Osteoarthritis: A Case Report


Journal of Medical Case Reports // LOE: V


Single case of a 57-year-old man with bilateral moderate-to-severe knee OA treated with ultrasound-guided intra-articular PRP.  Over a period of 15 months, he received a total of 34 bilateral injections, with NRS, WOMAC, and follow-up MRI as outcomes.


Key Findings:

  • Both NRS and WOMAC improved significantly by final follow-up, with better joint function and quality of life

  • MRI showed improved meniscal morphology and reduced inflammatory parameters (bone marrow edema, effusion, infrapatellar fat pad swelling, synovitis)


Clinical Perspective:


The imaging improvements are real and worth acknowledging, but the treatment burden is unreasonable.  34 injections across two knees over 15 months is an extraordinary amount of needling to reach a good outcome, with platelet concentration and per-injection dose never reported.  It's the same pattern we see again and again, a low-dose or uncharacterized protocol compensated for by sheer repetition.  


Why subject a patient to 34 injections to achieve what an adequately dosed PRP aims to deliver in a handful?  Dose does the work, repetition is what you resort to when the dose per session is too low.



 
 
 
bottom of page